AR020017A1 - Integracion osea - Google Patents

Integracion osea

Info

Publication number
AR020017A1
AR020017A1 ARP990106158A ARP990106158A AR020017A1 AR 020017 A1 AR020017 A1 AR 020017A1 AR P990106158 A ARP990106158 A AR P990106158A AR P990106158 A ARP990106158 A AR P990106158A AR 020017 A1 AR020017 A1 AR 020017A1
Authority
AR
Argentina
Prior art keywords
integration
endoprotesis
osea
salts
ibandronate
Prior art date
Application number
ARP990106158A
Other languages
English (en)
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of AR020017A1 publication Critical patent/AR020017A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

Uso de ácido ibandronico (ácido 1-hidroxi-3-(N-metil-N-pentil)aminopropil-1,1-difosfonico) o sales fisiologicamente compatibles o ésteres del mismo paramejorar la integracion osea de endoprotesis ancladas libres de cemento. Ibandronato o las salesde l mismo se administran durante un tiempo corto,inmediatamente después de la insercion de una endoprotesis, con el resultado sorprendente de que se obtiene la estabilidad secundaria del implante en solo 5semanas o menos después de la operacion.
ARP990106158A 1998-12-04 1999-12-03 Integracion osea AR020017A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19855976 1998-12-04

Publications (1)

Publication Number Publication Date
AR020017A1 true AR020017A1 (es) 2002-03-27

Family

ID=7889968

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106158A AR020017A1 (es) 1998-12-04 1999-12-03 Integracion osea

Country Status (17)

Country Link
US (1) US6680307B1 (es)
EP (2) EP1614422A3 (es)
JP (1) JP3793023B2 (es)
KR (1) KR100453779B1 (es)
CN (1) CN1173704C (es)
AR (1) AR020017A1 (es)
AT (1) ATE303153T1 (es)
AU (1) AU756540B2 (es)
BR (1) BR9915927A (es)
CA (1) CA2353528C (es)
DE (1) DE69927048T2 (es)
DK (1) DK1135140T3 (es)
ES (1) ES2247842T3 (es)
PT (1) PT1135140E (es)
TR (1) TR200101546T2 (es)
WO (1) WO2000033849A1 (es)
ZA (1) ZA200104140B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001287260A1 (en) * 2000-07-12 2002-01-21 Ecole Polytechnique Federale De Lausanne (Epfl) Active biocoating for bone implant
JP2002332235A (ja) * 2001-02-01 2002-11-22 Riderway Corp 骨疾患治療用液体医薬組成物
HUP0402267A3 (en) * 2001-12-21 2007-05-29 Procter & Gamble Method for treatment of bone disorders
BR0308901A (pt) * 2002-05-10 2005-01-04 Hoffmann La Roche ácidos bisfosfÈnicos para tratamento e prevenção de osteoporose
ES2530791T3 (es) * 2002-12-20 2015-03-05 Hoffmann La Roche Formulación de ibandronato de altas dosis
EP1508343B1 (en) * 2003-08-21 2015-11-04 AddBIO AB Bisphosponate coated implant device and method therefor
LT2662380T (lt) * 2005-02-01 2019-03-12 Atnahs Pharma Uk Limited Ibandronato polimorfo a medicininis panaudojimas
EP2610261A1 (en) * 2005-02-01 2013-07-03 F. Hoffmann-La Roche AG Ibandronate polymorph B
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0675723A4 (en) * 1992-12-23 1998-08-05 Merck & Co Inc THERAPY USING BISPHOSPHONATES AND STROGENS TO TREAT AND PREVENT BONE RESORPTION.
US5403829A (en) 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FI92465C (fi) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
AU5973496A (en) * 1995-06-06 1996-12-24 Merck & Co., Inc. Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
US6022887A (en) * 1996-12-13 2000-02-08 Osteoscreen, Inc. Compositions and methods for stimulating bone growth

Also Published As

Publication number Publication date
KR100453779B1 (ko) 2004-10-20
EP1135140B1 (en) 2005-08-31
CA2353528C (en) 2007-04-24
JP3793023B2 (ja) 2006-07-05
TR200101546T2 (tr) 2001-11-21
CN1329495A (zh) 2002-01-02
EP1135140A1 (en) 2001-09-26
ZA200104140B (en) 2002-08-21
EP1614422A2 (en) 2006-01-11
DE69927048D1 (de) 2005-10-06
EP1614422A3 (en) 2009-02-18
DE69927048T2 (de) 2006-06-08
KR20010093137A (ko) 2001-10-27
JP2002531509A (ja) 2002-09-24
US6680307B1 (en) 2004-01-20
CN1173704C (zh) 2004-11-03
BR9915927A (pt) 2001-08-21
AU1557700A (en) 2000-06-26
ES2247842T3 (es) 2006-03-01
AU756540B2 (en) 2003-01-16
ATE303153T1 (de) 2005-09-15
PT1135140E (pt) 2005-10-31
CA2353528A1 (en) 2000-06-15
DK1135140T3 (da) 2005-12-19
WO2000033849A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
ES2150979T3 (es) Formulado de acidos bisfosfonicos a partir de una mezcla seca.
BG104265A (en) Pharmaceutical preparation containing clodronate as an active component and silication microcrystalline cellulose as a filler
MX9307686A (es) Preparacion de liberacion sostenida.
DE69328973D1 (de) Intraokulare prothese
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
DE69201725D1 (de) Behandlungsmethoden für osteoporose.
UY23665A1 (es) Procedimiento para la preparacion de compuesto farmaceutico
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
CA2035179A1 (en) Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
ES2184302T3 (es) Procedimiento para la preparacion del acido 1,4,7,10-tetraazaciclododecano-1,4,7-triacetico y derivados del mismo.
EP1614422A3 (en) Ibandronate for the promotion of osseointegration of endoprostheses
ES2062664T3 (es) Poli(acido alfa-hidroxilacrilico) y derivados como compuestos activos antisarro en composiciones orales.
ATE331502T1 (de) 4-amino-1-hydroxybutyliden-1,1-biphosphonsäure enthaltende direktkomprimierte tablette
IS1801B (is) Pýridýlbisfosfónöt til notkunar sem efni til lækninga
DE59809717D1 (de) Implantat, insbesondere zahnwurzelimplantat
FI945866A0 (fi) Ennaltaehkäisevä ja hoitava valmiste kariesta vastaan
AR038041A1 (es) Metodo para el tratamiento de trastornos oseos
ES2152865A1 (es) Utilizacion de bisfosfonatos en la preparacion de composiciones farmaceuticas para uso intramuscular.
NO308195B1 (no) Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF
BR9907195A (pt) " formulações de tiagabina de liberação prolongada com efeitos colaterais reduzidos "
AR013500A1 (es) Uso de acido alendronico o una sal farmaceuticamente aceptable del mismo o una mezcal de los mismos para la manufactura de un medicamento
沈一慶 et al. Osteoporosis and Periodontal Disease
NO20042603L (no) Doble estere
UY23640A1 (es) Procedimiento de elaboracion de fosfato de levamisol inyectable
IT7860904V0 (it) Scarpa femminile nella quale la suola, il tacco e la zeppa metatarsale sono apprestati dall'accoppiamento di due pezzi, caratterizzata dal fatto che la suola e' incassata all'esterno della zeppa metatarsale per una lunghezza preponderante di quest'ultima.

Legal Events

Date Code Title Description
FC Refusal